Axsome Therapeutics Inc (AXSM) valuation

$145.04

Latest weekly close · Market cap $7.5B

Share AXSM P/S history
Historically low

As of

AXSM's P/S of 9.7x is the lowest of its weekly readings since February 2024.

Weekly P/S since February 2024

P/S each weekMiddle half of its readingsMedian 13.8×
P/S weekly history5×10×15×20×9.7×202420252026
Median
13.8×
Low to high
9.7×–18.7×
Versus median
-30%
History starts
February 2024

P/S

<1stpercentile

of its weekly readings since February 2024

Historically low

Growth, last 12 months vs the year before

Revenue
+57%slowing
EPS
n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading
0100200300400202420252026

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

AXSM P/S at each year-end
Year-endP/SP/EEV/SalesEV/EBITDA5-year percentile
15.9×n/a15.7×n/a94
12.3×n/a11.9×n/a10

Loading peers and related research…

About this history

What is AXSM's current P/S?
AXSM's P/S of 9.7x is the lowest of its weekly readings since February 2024.
What is AXSM's five-year median P/S?
13.8x. Half of AXSM's weekly readings since February 2024 were higher and half were lower. This page has 140 weekly readings, from Feb 19, 2024 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares AXSM only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built